Ocular Therapeutix Inc (OCUL)
Healthcare
Biotechnology
8.40 $
+2.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Ocular Therapeutix Inc (OCUL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 13 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 15 | 15 | 16 | 15 | 17 | 11 | 13 | 15 | 13 | 11 | 13 | 52 | |
| 1.4 | 1.4 | 1.3 | 1.5 | 1.6 | 1.2 | 1.3 | 1.9 | 1.8 | 1.6 | 1.3 | 2.0 | 6.7 | |
| 14 | 13 | 13 | 15 | 14 | 16 | 9.4 | 12 | 13 | 12 | 9.5 | 11 | 45 | |
| 15 | 16 | 21 | 29 | 37 | 41 | 43 | 51 | 52 | 51 | 66 | 54 | 224 | |
| 17 | 44 | 23 | 20 | 12 | 24 | 29 | 27 | 16 | 18 | 20 | 22 | 76 | |
| 33 | 33 | 45 | 59 | 60 | 66 | 73 | 79 | 81 | 81 | 103 | 94 | 359 | |
| -19 | -20 | -32 | -44 | -46 | -51 | -64 | -68 | -69 | -70 | -93 | -82 | -314 | |
| 3.4 | 4.2 | 4.1 | 3.2 | 3.2 | 3.1 | 3.0 | 3.0 | 3.0 | 2.8 | 2.8 | 2.8 | 11 | |
| -0.5 | -29 | -65 | -44 | -36 | -48 | -64 | -68 | -69 | -65 | -89 | -79 | -301 | |
| -0.9 | -7.2 | -0.9 | – | – | – | – | – | – | – | – | – | – | |
| -0.5 | -29 | -65 | -44 | -36 | -48 | -64 | -68 | -69 | -65 | -89 | -79 | -301 | |
| 3.8 | -24 | -60 | -40 | -32 | -44 | -60 | -64 | -65 | -61 | -85 | -76 | -286 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.